Wednesday, July 8, 2026

pharma · Recurrent Pericarditis · Sjögren’s Disease · KNSA

Kiniksa Pharmaceuticals International

Kiniksa Pharmaceuticals International trial registry — 16 ClinicalTrials.gov studies with program phase, status, and indication context.

100 Hayden Ave, Lexington, Massachusetts 02421, US HQ
2015 Founded
381 Employees
Public company Type
KNSA · NYSE Ticker
Company details
Status
Public
HQ
100 Hayden Ave, Lexington, Massachusetts 02421, US
Founded
2015
Employees
381
Programs
14
Drugs
7
Patents
9
Intelligence · Clinical Trials

Kiniksa Pharmaceuticals International clinical trials

Registry index of 16 ClinicalTrials.gov studies linked to Kiniksa Pharmaceuticals International programs — each row shows trial ID, program name, phase, status, and indication.

Kiniksa Pharmaceuticals International trial registry — 16 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Kiniksa Pharmaceuticals International.

  1. KPL-404-C221 — Phase 2

    Clinical update
  2. Mavrilimumab — Phase 2

    Clinical update
  3. mavrilimumab — Phase 3

    Clinical update
  4. KPL-387 — Phase 2

    Clinical update
  5. mavrilimumab — Phase 2

    Clinical update
  6. KPL-716 — Phase 2

    Clinical update
  7. KPL-387 — Phase 3

    Clinical update
  8. Rilonacept — Phase 3

    Clinical update

Trial registry

16 studies